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Background
Pathogenic spirochetes from the genus Leptospira are
the bacteria that cause leptospirosis, an emerging zoono-
sis responsible for over 500,000 human cases each year
[1]. Vaccination with inactivated whole-cell preparations
(bacterins) has limited efficacy due to the wide antigenic
variation of the pathogen. Bacterins are reactogenic and
confers serovar specific and short-term immunity [2].
The protein OmpL37 represents a potential target for
vaccine development against leptospirosis since it is
recognized by human and animal serum, binds human
extracellular matrix components, is up-regulated in vivo
and conserved among pathogenic leptospires [3]. We
aimed to evaluate the immune response induced by
OmpL37 from L. interrogans serovar Copenhageni strain
Fiocruz L1-130 in hamsters, using prime-boost, DNA,
and protein-based immunizations.
Methods
The ompL37 gene was cloned into pAE and pTargeT vec-
tors, to obtain a subunit and a DNA vaccine, respectively.
The recombinant protein OmpL37 (rOmpL37) was char-
acterized by Western blot (WB) and pTargeT/ompL37
was evaluated by transfection of CHO-K1 cells and ana-
lyzed by immunofluorescence. Groups of 6 hamsters were
immunized twice with an interval of 21 days as follows:
rOmpL37-Alhydrogel (2x 100 µg), pTargeT-ompL37 (2x
100 µg), prime-boost pTargeT-ompL37 (100 µg) plus
rOmpL37 (100 µg), pTargeT (2x 100 µg) and PBS-
Alhydrogel. Two independent experiments were con-
ducted. Pooled blood samples, collected at days 0, 21 and
42, were processed for RNA isolation using the RiboPure-
Blood Kit (Ambion). cDNA synthesis was performed using
the High-Capacity cDNA Reverse Transcription Kits
(Applied Biosystems). Expression profiles of IFN-g, TNF-
a, IL1-a and TGF-b were accessed by quantitative real-
time PCR using SYBR Green PCR Master Mix (Applied
Biosystems). The relative Ct (ΔΔCT) method was used to
quantify cytokine gene expression. The CT of each test
gene was evaluated in pooled hamster whole-blood sam-
ples, the CTs were normalized against the b-actin gene
CT (ΔCT) and then compared to the same normalized
gene in the respective control groups (calibrator) [4].
Results and conclusion
Considering that target genes are up or down-regulated
when a 2-fold change in mRNA levels is observed [5],
TNF-a was induced by rOmpL37 at day 42 (ratio = 2.84),
and by pTargeT/ompL37 at days 21 and 42 (ratio > 5). In
contrast, IFN-g was down regulated in the prime-boost
group at day 42 (ratio = 0.41). Similarly, down-regulation
of IL1-a was observed at day 42 in the pTargeT/ompL37
(ratio = 0.28) and prime-boost (ratio = 0.19) groups.
TGF-b was expressed at basal levels in all groups. Both
rOmpL37 and pTargeT/ompL37 were able to induce a
pro-inflammatory response, characterized by increased
TNF-a expression. However, the Th1 and pro-inflamma-
tory cytokine levels decreased in the prime-boost group.
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